Advertisement

Current Environmental Health Reports

, Volume 4, Issue 2, pp 229–243 | Cite as

Arsenic and Immune Response to Infection During Pregnancy and Early Life

  • Sarah E. Attreed
  • Ana Navas-Acien
  • Christopher D. HeaneyEmail author
Mechanisms of Toxicity (JR Richardson, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Mechanisms of Toxicity

Abstract

Purpose of Review

Arsenic, a known carcinogen and developmental toxicant, is a major threat to global health. While the contribution of arsenic exposure to chronic diseases and adverse pregnancy and birth outcomes is recognized, its ability to impair critical functions of humoral and cell-mediated immunity—including the specific mechanisms in humans—is not well understood. Arsenic has been shown to increase risk of infectious diseases that have significant health implications during pregnancy and early life. Here, we review the latest research on the mechanisms of arsenic-related immune response alterations that could underlie arsenic-associated increased risk of infection during the vulnerable periods of pregnancy and early life.

Recent Findings

The latest evidence points to alteration of antibody production and transplacental transfer as well as failure of T helper cells to produce IL-2 and proliferate.

Summary

Critical areas for future research include the effects of arsenic exposure during pregnancy and early life on immune responses to natural infection and the immunogenicity and efficacy of vaccines.

Keywords

Arsenic exposure Immune response Infection Immunotoxicity Pregnant women Newborns Children 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Funding Sources

The authors would like to acknowledge their funding sources: NIH grants 1R01ES026973-01A1, R01ES021367, and R01ES025216.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009;29:381–99.CrossRefPubMedGoogle Scholar
  2. 2.
    George CM, et al. Arsenic exposure in drinking water: an unrecognized health threat in Peru. Bull World Health Organ. 2014;92(8):565–72.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Abdul KS, et al. Arsenic and human health effects: a review. Environ Toxicol Pharmacol. 2015;40(3):828–46.CrossRefPubMedGoogle Scholar
  4. 4.
    Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: a review. Environ Health. 2013;12:73.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    IARC, Arsenic and Arsenic Compounds. 2012Google Scholar
  6. 6.
    Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998;44:185–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Dietert RR. Developmental immunotoxicity, perinatal programming, and noncommunicable diseases: focus on human studies. Adv Med. 2014;2014:867805.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Diamond MP, Gabriele R. Effects of pregnancy on metabolism. Comprehensive physiology. Hoboken: John Wiley & Sons, Inc.; 2011.Google Scholar
  9. 9.
    Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–33.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lantz RC, et al. Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble As(III) and As(V). Environ Res. 1994;67(2):183–95.CrossRefPubMedGoogle Scholar
  11. 11.
    Banerjee N, et al. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol. 2009;29(5):582–94.CrossRefPubMedGoogle Scholar
  12. 12.
    Biswas R, et al. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol. 2008;27(5):381–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Hernandez-Castro B, et al. Effect of arsenic on regulatory T cells. J Clin Immunol. 2009;29(4):461–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Soto-Pena GA, Vega L. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol Appl Pharmacol. 2008;230(2):216–26.CrossRefPubMedGoogle Scholar
  15. 15.
    Sikorski EE, et al. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam Appl Toxicol. 1989;13(4):843–58.CrossRefPubMedGoogle Scholar
  16. 16.
    Lemarie A, et al. Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol. 2006;177(5):3019–27.CrossRefPubMedGoogle Scholar
  17. 17.
    Soto-Pena GA, et al. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 2006;20(6):779–81.PubMedGoogle Scholar
  18. 18.
    • Ahmed S, et al. Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh. Toxicol Sci. 2014;141(1):166–75. In this MINIMat substudy, authors use data collected prospectively from pregnant mothers and their children to associate recent and prenatal arsenic exposure with T cell-mediated immunologic memory. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Blakley BR, Sisodia CS, Mukkur TK. The effect of methylmercury, tetraethyl lead, and sodium arsenite on the humoral immune response in mice. Toxicol Appl Pharmacol. 1980;52(2):245–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Islam LN, et al. Association of respiratory complications and elevated serum immunoglobulins with drinking water arsenic toxicity in human. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2007;42(12):1807–14.CrossRefPubMedGoogle Scholar
  21. 21.
    Ser, P.H., et al., Arsenic exposure increases maternal but not cord serum IgG in Bangladesh. Pediatr Int. 2014;57(1):119–125.Google Scholar
  22. 22.
    Nain S, Smits JE. Pathological, immunological and biochemical markers of subchronic arsenic toxicity in rats. Environ Toxicol. 2012;27(4):244–54.CrossRefPubMedGoogle Scholar
  23. 23.
    Patra PH, et al. Immunotoxic and genotoxic potential of arsenic and its chemical species in goats. Toxicol Int. 2013;20(1):6–10.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Saha A, et al. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children. Vaccine. 2013;31(4):647–52.CrossRefPubMedGoogle Scholar
  25. 25.
    Farzan SF, et al. In utero arsenic exposure and infant infection in a United States cohort: a prospective study. Environ Res. 2013;126:24–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Kile ML, et al. A prospective cohort study of the association between drinking water arsenic exposure and self-reported maternal health symptoms during pregnancy in Bangladesh. Environ Health. 2014;13(1):29.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Dangleben NL, Skibola CF, Smith MT. Arsenic immunotoxicity: a review. Environ Health. 2013;12(1):73.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Rahman A, et al. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119(5):719–24.CrossRefPubMedGoogle Scholar
  29. 29.
    •• Ramsey KA, et al. Early life arsenic exposure and acute and long-term responses to influenza A infection in mice. Environ Health Perspect. 2013;121(10):1187–93. This study outlines an in vivo model of prenatal arsenic exposure and neonatal immune challenge. PubMedPubMedCentralGoogle Scholar
  30. 30.
    Raqib R, et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185(3):197–202.CrossRefPubMedGoogle Scholar
  31. 31.
    •• Heaney CD, et al. Arsenic exposure and hepatitis E virus infection during pregnancy. Environ Res. 2015;142:273–80. This study provides an example of a prospective cohort study assessing the immunotoxic effects of arsenic exposure during the pregnancy and postpartum periods. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Smith AH, et al. Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am J Epidemiol. 2011;173(4):414–20.CrossRefPubMedGoogle Scholar
  33. 33.
    Murphy KTP, Walport M. Immunobiology. Seventh ed. New York: Garland Science, Taylor & Francis Group, LLC; 2008.Google Scholar
  34. 34.
    Brambell FW. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet. 1966;2(7473):1087–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Palmeira P, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:985646.CrossRefPubMedGoogle Scholar
  36. 36.
    Gendrel D, et al. Placental transfer of tetanus antibodies and protection of the newborn. J Trop Pediatr. 1990;36(6):279–82.CrossRefPubMedGoogle Scholar
  37. 37.
    Hartter HK, et al. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J. 2000;19(7):635–41.CrossRefPubMedGoogle Scholar
  38. 38.
    Goncalves G, et al. Transplacental transfer of measles and total IgG. Epidemiol Infect. 1999;122(2):273–9.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Silveira Lessa AL, et al. Preterm and term neonates transplacentally acquire IgG antibodies specific to LPS from Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2011;62(2):236–43.CrossRefPubMedGoogle Scholar
  40. 40.
    Islam LN, et al. Function of serum complement in drinking water arsenic toxicity. J Toxicol. 2012;2012:302817.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Cardenas A, et al. Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010). Environ Health Perspect. 2015;123(6):590–6.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Cardenas A, et al. Arsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012. Epidemiol Infect. 2016;144(8):1641–51.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Martin-Chouly C, et al. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol Immunol. 2011;48(6–7):956–65.CrossRefPubMedGoogle Scholar
  44. 44.
    Conde P, et al. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch Toxicol. 2007;81(4):251–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Galicia G, et al. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int Immunopharmacol. 2003;3(5):671–82.CrossRefPubMedGoogle Scholar
  46. 46.
    Tenorio EP, Saavedra R. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes. Int Immunopharmacol. 2005;5(13–14):1853–69.CrossRefPubMedGoogle Scholar
  47. 47.
    Vega L, et al. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol Immunotoxicol. 1999;21(2):203–20.CrossRefPubMedGoogle Scholar
  48. 48.
    Vega L, et al. Helper T cell subpopulations from women are more susceptible to the toxic effect of sodium arsenite in vitro. Toxicology. 2004;199(2–3):121–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Mozdzanowska K, et al. Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies. J Virol. 2005;79(10):5943–51.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Akao Y, et al. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br J Haematol. 1998;102(4):1055–60.CrossRefPubMedGoogle Scholar
  51. 51.
    Burchiel SW, et al. Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid. PLoS One. 2014;9(10):e109192.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Ahmed S, et al. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci. 2012;129(2):305–14.CrossRefPubMedGoogle Scholar
  53. 53.
    Nadeau, K.C., et al., In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort. Clin Immunol. 2014;155(2):188–197.Google Scholar
  54. 54.
    Kile ML, et al. Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014;9(5):774–82.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    NCBI, CD151 CD151 molecule (Raph Blood Group) [Homo sapiens (humans)]. 2016.Google Scholar
  56. 56.
    Bailey KA, et al. Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014;139(2):328–37.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Heck JE, et al. Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood. Int J Hyg Environ Health. 2014;217(6):662–8.CrossRefPubMedGoogle Scholar
  58. 58.
    Xu HM, Medina S, Lauer FT, Douillet C, Liu KJ, Hudson LG, Styblo M, Burchiel SW. Differential sensitivities of bone marrow, spleen and thymus to genotoxicity induced by environmentally relevant concentrations of arsenite. Toxicol Lett. 2016;262:55–61.CrossRefPubMedGoogle Scholar
  59. 59.
    Patterson R, et al. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicol Appl Pharmacol. 2004;198(3):434–43.CrossRefPubMedGoogle Scholar
  60. 60.
    Kozul CD, et al. Low-dose arsenic compromises the immune response to influenza a infection in vivo. Environ Health Perspect. 2009;117(9):1441–7.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Goytia-Acevedo RC, Cebrian ME, Calderon-Aranda ES. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes. Toxicology. 2003;189(3):235–44.CrossRefPubMedGoogle Scholar
  62. 62.
    Cho Y, et al. Age-related effects of sodium arsenite on splenocyte proliferation and Th1/Th2 cytokine production. Arch Pharm Res. 2012;35(2):375–82.CrossRefPubMedGoogle Scholar
  63. 63.
    • Xu H, et al. Environmentally relevant concentrations of arsenite and monomethylarsonous acid inhibit IL-7/STAT5 cytokine signaling pathways in mouse CD3+CD4-CD8- double negative thymus cells. Toxicol Lett. 2016;247:62–8. This recent article provides novel insight into the potential immune signaling cascades responsible for arsenic-induced immunotoxicity. CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Ezeh PC, et al. Monomethylarsonous acid (MMA+3) inhibits IL-7 signaling in mouse pre-B cells. Toxicol Sci. 2016;149(2):289–99.CrossRefPubMedGoogle Scholar
  65. 65.
    Ramsey KA, et al. In utero exposure to arsenic alters lung development and genes related to immune and mucociliary function in mice. Environ Health Perspect. 2013;121(2):244–50.PubMedGoogle Scholar
  66. 66.
    Smith AH, et al. Chronic respiratory symptoms in children following in utero and early life exposure to arsenic in drinking water in Bangladesh. Int J Epidemiol. 2013;42(4):1077–86.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Mazumder DNG, et al. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 2005;16(6):760–5.CrossRefPubMedGoogle Scholar
  68. 68.
    Burggren WW, Mueller CA. Developmental critical windows and sensitive periods as three-dimensional constructs in time and space. Physiol Biochem Zool. 2015;88(2):91–102.CrossRefPubMedGoogle Scholar
  69. 69.
    De Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. Australian and New Zealand Journal of Obstetrics and Gynaecolog. 2006;46:4–14.CrossRefGoogle Scholar
  70. 70.
    Okae H, et al. Genome-wide analysis of DNA methylation dynamics during early human development. PLoS Genet. 2014;10(12):e1004868.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Skogen JC, Overland S. The fetal origins of adult disease: a narrative review of the epidemiological literature. JRSM Short Rep. 2012;3(8):59.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307(4):391–7.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Heilmann C, et al. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med. 2006;3(8):e311.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Heilmann C, Budtz-Jørgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect. 2010;118(10):1434–8.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Jusko TA, et al. A birth cohort study of maternal and infant serum PCB-153 and DDE concentrations and responses to infant tuberculosis vaccination. Environ Health Perspect. 2016;124(6):813–21.PubMedGoogle Scholar
  76. 76.
    Kraus TA, et al. Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 2012;32(2):300–11.CrossRefPubMedGoogle Scholar
  77. 77.
    CDC, Flu Vaccine Safety and Pregnancy. 2016Google Scholar
  78. 78.
    CDC, Immunization Schedule: Child and Adolescent Schedule. 2016Google Scholar
  79. 79.
    Ser PH, et al. Arsenic exposure increases maternal but not cord serum IgG in Bangladesh. Pediatr Int. 2015;57(1):119–25.CrossRefPubMedGoogle Scholar
  80. 80.
    Howe CG, et al. Folate and cobalamin modify associations between S-adenosylmethionine and methylated arsenic metabolites in arsenic-exposed Bangladeshi adults. J Nutr. 2014;144(5):690–7.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Hall MN, et al. Folate, cobalamin, cysteine, homocysteine, and arsenic metabolism among children in Bangladesh. Environ Health Perspect. 2009;117(5):825–31.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Hall M, et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect. 2007;115(10):1503–9.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Petrick JS, et al. Inorganic arsenic as a developmental toxicant: in utero exposure and alterations in the developing rat lungs. Mol Nutr Food Res. 2009;53(5):583–91.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Sarah E. Attreed
    • 1
  • Ana Navas-Acien
    • 1
    • 2
    • 3
  • Christopher D. Heaney
    • 1
    • 2
    Email author
  1. 1.Department of Environmental Health and EngineeringJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Department of Environmental Health Sciences, Mailman School of Public HealthColumbia UniversityNew YorkUSA

Personalised recommendations